Search the collection

49 results for calmangafodipir

Sort by:

Sort by

Limit results to:

20 per page

49 results for calmangafodipir

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
Author / Creator:Pfeiffer, Per ; Lustberg, Maryam ; Näsström, Jacques ; Carlsson, Stefan ; Persson, Anders ; Nagahama, Fumiko ; Cavaletti, Guido ; Glimelius, Bengt ; Muro, Kei
Publisher:Oxford: Oxford University Press
Journal title:JNCI cancer spectrum, 2022-11, Vol.6 (6)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594
Author / Creator:Stehr, Jan Eric ; Lundström, Ingemar ; Karlsson, Jan Olof G.
Publisher:Basel: MDPI AG
Journal title:Antioxidants, 2020-09, Vol.9 (9), p.802
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
Author / Creator:Canta, Annalisa ; Chiorazzi, Alessia ; Pozzi, Eleonora ; Fumagalli, Giulia ; Monza, Laura ; Meregalli, Cristina ; Carozzi, Valentina A. ; Rodriguez-Menendez, Virginia ; Oggioni, Norberto ; Näsström, Jacques ; Marmiroli, Paola ; Cavaletti, Guido
Publisher:Basel: MDPI AG
Journal title:Antioxidants, 2020-07, Vol.9 (7), p.594
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose o...
Author / Creator:Dear, James
Publisher:England: BioMed Central Ltd
Journal title:Current controlled trials in cardiovascular medicine, 2019-01, Vol.20 (1), p.27-27, Article 27
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the...
Author / Creator:Karlsson, Jan Olof G. ; Jynge, Per ; Lundström, Ingemar ; Ignarro, Louis J.
Publisher:England: BioMed Central Ltd
Journal title:Current controlled trials in cardiovascular medicine, 2019-06, Vol.20 (1), p.380-380, Article 380
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Reply to a Comment Paper on the Published Paper by Canta, A. et al: “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced P...
Author / Creator:Canta, Annalisa ; Chiorazzi, Alessia ; Pozzi, Eleonora ; Fumagalli, Giulia ; Monza, Laura ; Meregalli, Cristina ; Carozzi, Valentina A. ; Rodriguez-Menendez, Virginia ; Oggioni, Norberto ; Näsström, Jacques ; Marmiroli, Paola ; Cavaletti, Guido
Publisher:Basel: MDPI AG
Journal title:Antioxidants, 2020-09, Vol.9 (9), p.807
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe...
Author / Creator:Karlsson, Jan Olof ; Jynge, Per ; Lundström, Ingemar ; Ignarro, Louis J.
Journal title:Trials, 2019-06, Vol.20
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca4Mn(DPDP)5, MnDPDP and DPDP
Author / Creator:Karlsson, Jan Olof G. ; Jynge, Per
Publisher:Basel: MDPI AG
Journal title:International journal of molecular sciences, 2024-04, Vol.25 (8), p.4347
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn[sup.2+] and Oxaliplatin-Associated Pt[sup.2+]
Author / Creator:Karlsson, Jan Olof G ; Jynge, Per ; Ignarro, Louis J
Publisher:MDPI AG
Journal title:Antioxidants, 2023-03, Vol.12 (3)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx
Author / Creator:Karlsson, Jan Olof G. ; Jynge, Per ; Ignarro, Louis J.
Publisher:Switzerland: MDPI AG
Journal title:Antioxidants, 2021-12, Vol.10 (12), p.1937
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2
Author / Creator:Karlsson, Jan Olof G. ; Jynge, Per ; Ignarro, Louis J.
Publisher:Basel: MDPI AG
Journal title:Antioxidants, 2023-03, Vol.12 (3), p.608
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesFull Text
University of Milano Bicocca Researchers Focus on Oxaliplatin Therapy (Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2020-07, p.6524
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesFull Text
Patent Issued for Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment (USPTO 9597334)
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2017-04, p.4679
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesFull Text
Data on Respiratory Inhalant Products Described by Researchers at University of Edinburgh [Principal Results of a Randomised Open Label Exploratory, Safety and Tolerability Study With Calmangafodipir...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2019-10, p.536
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesFull Text
Patent Application Titled "Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment" Published Online (USPTO 20160038507)
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2016-03, p.1916
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newsletter articlesFull Text
PledPharma announces US patent receipt for method of treatment related to calmangafodipir
Publisher:London: Normans Media Ltd
Journal title:M2 EquityBites, 2020
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
Newsletter articlesFull Text
PledPharma announces US patent receipt for method of treatment related to calmangafodipir
Publisher:London: Normans Media Ltd
Journal title:M2 Pharma, 2020
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
Newsletter articlesFull Text
Drugs and Therapies - Oxaliplatin Therapy; University of Milano Bicocca Researchers Focus on Oxaliplatin Therapy (Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers L...
Publisher:Atlanta: NewsRx
Journal title:Drug Week, 2020, p.6524
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
Newsletter articlesFull Text
PledPharma AB; Patent Issued for Calmangafodipir, A New Chemical Entity, And Other Mixed Metal Complexes, Methods Of Preparation, Compositions, And Methods Of Treatment (USPTO 10,111,893)
Publisher:Atlanta: NewsRx
Journal title:Obesity, Fitness & Wellness Week, 2018, p.494
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
Newsletter articlesFull Text
PledPharma (PLED) issued patent titled "Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment"
Publisher:Melbourne: News Bites Pty Ltd
Journal title:News Bites - Consumer Durables & Apparel, 2018
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 49 results

Export record to excel

Export this record

Export record to excel

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Export this record

Export record to excel

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594

Export this record

Export record to excel

Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity

Export this record

Export record to excel

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose o...

Export this record

Export record to excel

Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the...

Export this record

Export record to excel

Reply to a Comment Paper on the Published Paper by Canta, A. et al: “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced P...

Export this record

Export record to excel

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe...

Export this record

Export record to excel

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca4Mn(DPDP)5, MnDPDP and DPDP

Export this record

Export record to excel

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn[sup.2+] and Oxaliplatin-Associated Pt[sup.2+]

Export this record

Export record to excel

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx

Export this record

Export record to excel

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2

Export this record

Export record to excel

University of Milano Bicocca Researchers Focus on Oxaliplatin Therapy (Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced...

Export this record

Export record to excel

Patent Issued for Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment (USPTO 9597334)

Export this record

Export record to excel

Data on Respiratory Inhalant Products Described by Researchers at University of Edinburgh [Principal Results of a Randomised Open Label Exploratory, Safety and Tolerability Study With Calmangafodipir...

Export this record

Export record to excel

Patent Application Titled "Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment" Published Online (USPTO 20160038507)

Export this record

Export record to excel

PledPharma announces US patent receipt for method of treatment related to calmangafodipir

Export this record

Export record to excel

PledPharma announces US patent receipt for method of treatment related to calmangafodipir

Export this record

Export record to excel

Drugs and Therapies - Oxaliplatin Therapy; University of Milano Bicocca Researchers Focus on Oxaliplatin Therapy (Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers L...

Export this record

Export record to excel

PledPharma AB; Patent Issued for Calmangafodipir, A New Chemical Entity, And Other Mixed Metal Complexes, Methods Of Preparation, Compositions, And Methods Of Treatment (USPTO 10,111,893)

Export this record

Export record to excel

PledPharma (PLED) issued patent titled "Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment"

Refine your search